Prosecution Insights
Last updated: October 25, 2026

Jcip Global Inc.

Technology areas: Chemistry & Materials • Medical Devices & Mechanical Engineering

57 pending office actions • 10 clients • 49 examiners • 29 art units • 0 of 57 (0%) have an AI response strategy ready

Analysis

JCIP GLOBAL INC. handles Medical Devices & Mechanical Engineering matters and reports 56542 career applications. Its resolved allowance rate is 87.15%, with 53 pending office actions. The career-application total indicates a substantial recorded prosecution history, while the allowance rate provides an outcome measure for resolved applications.

The average of 2.6 office actions per allowance shows that allowed matters have generally involved more than one examination exchange. For clients assessing prosecution strategy, these figures provide a basis for balancing a high resolved allowance rate with the response work associated with continued examination. The 53 pending office actions represent the currently active portion of the docket and make workload monitoring an important practical consideration.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Quality Metrics (n=56542 apps, methodology: how we score firms)

87.2%
Allowance Rate
n=56542
+0.43σ
Allowance Rate (norm)
n=56542
2.6
OAs to Allowance
n=38889
-0.46σ
OAs to Allow (norm)
n=38889
875 days
Time to Allowance
n=38889
+4.5pp
Interview Lift
n=56542
21.0%
RCE Rate
n=56542
0.4%
Appeal Rate
n=56542

Rejection Performance (% of received rejections ultimately overcome)

67.7%
§101 Overcome
n=2757
78.1%
§102 Overcome
n=18096
77.2%
§103 Overcome
n=26868
77.3%
§112 Overcome
n=13189

Specialization & Scale

G06F, H01L, H10W
Top CPC Subclasses
18%
Top-3 CPC Share
n=56542
1
Practitioners
n=56542
56542.0
Apps / Practitioner
n=56542

Portfolio Summary

57
Total Pending OAs
31
Non-Final OAs
24
Final Rejections
2
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 24 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

8
Overdue
3
Due this week
4
Due this month
2
Due in next 60 days
7
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 24 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (8)Due ≤ 7 days (3)Due ≤ 30 days (4)Due ≤ 60 days (2)Due later (7)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

23
Hard (40%)
30
Medium (53%)
4
Easy (7%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 only1 (2%)
§101 + other1 (2%)
§103 only29 (51%)
§102 only1 (2%)
§112 only4 (7%)
Multi-statute (no §101)21 (37%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

17
Life Sciences
30% of docket
2
Information Tech
4% of docket
1
Communications
2% of docket
8
Semiconductors
14% of docket
28
Mechanical / Eng
49% of docket
1
Business / Other
2% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

570 h
Manual time on pending OAs
114 h
Time saved (low, 20%)
200 h
Time saved (mid, 35%)
5.0 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
DOUGHERTY, SEAN PATRICK 3 74.5% +16.1%
SMALE, AVERY E 3 72.6% +18.4%
GLOVER, NELSON ALEXANDER 2 41.2% +49.8%
WITTLIFF, KATERINA ANNA 2 35.0% +18.8%
ESTES, JONATHAN WILLIAM 2 69.0% +6.5%
DIPERT, FORREST BLAKE 2 50.0% +64.4%
TRAN, KIM THANH THI 1 77.0% +24.6%
AHMED, SHAMIM 1 78.5% +22.1%
LEPISTO, RYAN A 1 87.7% +7.8%
LIU, CHU CHUAN 1 71.3% +14.9%

Hard Cases (23)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17746977 ENERGY STORAGE FRAME AND ENERGY STORAGE BATTERY CLUSTER JELSMA, JONATHAN G 134d overdue
18015079 BODY FLUID ANALYTE DETECTION DEVICE CATINA, MICHAEL ANTHONY 2d overdue
17955559 OPTICAL IMAGING SYSTEM FOR PRESENTING IMAGE OF PARTICLE LAPAGE, MICHAEL P 6d
18301960 ENERGY STORAGE CONTAINER AND ASSEMBLY METHOD THEREOF JONES, OLIVIA ANN 7d
18022755 NEEDLE MECHANISM MODULE FOR DRUG INFUSION DEVICE SMALE, AVERY E 12d
17978216 BATTERY CASE AND BATTERY DEVICE NEWMAN, DREW C 34d
17577348 SEQUENCING METHOD, SYSTEM AND KIT OF LOW MOLECULAR WEIGHT HEPARIN OLIGOSACCHARIDES VANNI, GEORGE STEVEN 62d
18694420 ANALYTE DETECTION DEVICE AND DETECTION METHOD TOTH, KAREN E 69d

Interview Candidates (15)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17434009 DRUG INFUSION DEVICE WITH MULTIPLE INFUSION MODES DIPERT, FORREST BLAKE 4d overdue
18022755 NEEDLE MECHANISM MODULE FOR DRUG INFUSION DEVICE SMALE, AVERY E 12d
17432095 MINIATURE PATCH-TYPE INTELLIGENT CONTROL INFUSION DEVICE DIPERT, FORREST BLAKE 16d
18022524 CLOSED-LOOP ARTIFICIAL PANCREAS INSULIN INFUSION CONTROL SYSTEM SMALE, AVERY E 22d
17924119 UNIDIRECTIONAL-DRIVEN DRUG INFUSION DEVICE WITTLIFF, KATERINA ANNA 30d
18695366 CALIBRATION FREE ANALYTE DETECTION DEVICE DOUGHERTY, SEAN PATRICK 40d
18576370 BODY FLUID ANALYTE DETECTION DEVICE GLOVER, NELSON ALEXANDER 69d
18269957 SKIN PATCH DRUG INFUSION DEVICE WITTLIFF, KATERINA ANNA 69d

Client Portfolio (10 clients)

Top Art Units

Art UnitApps
378315
379112
17232
17252
26151
17131
28741
28471
28991
28151

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19106212 MANAGEMENT DEVICE FOR DISPLAYING GLUCOSE INFORMATION Medtrum Technologies Inc. TRAN, KIM THANH THI 2615 §103 Non-Final OA — Pending Feb 25, 2025
18963535 MANUFACTURING METHOD FOR A PACKAGING SUBSTRATE Absolics Inc. AHMED, SHAMIM 1713 §103 Non-Final OA — Pending Nov 28, 2024
18896867 MANUFACTURING METHOD OF PACKAGING SUBSTRATE AND PACKAGING SUBSTRATE USING THE SAME Absolics Inc. LEPISTO, RYAN A 2874 §102§103§112 Non-Final OA — Pending Sep 25, 2024
18849534 ENERGY-EFFICIENT ANALYTE DETECTION SYSTEM Medtrum Technologies Inc. LIU, CHU CHUAN 3791 §103 Final Rejection — Pending Sep 23, 2024
18830630 MANUFACTURING METHOD OF PACKAGING SUBSTRATE AND PACKAGING SUBSTRATE USING THE SAME Absolics Inc. MAIGA, SIDI MOHAMED 2847 §103 Non-Final OA — Pending Sep 11, 2024
18814566 SUBSTRATE AND MANUFACTURING METHOD FOR THE SAME Absolics Inc. BENTON, CHLOE ELAINE 2899 §102§103 Non-Final OA — Pending Aug 25, 2024
18801628 LIGHT EMITTING DEVICE Kabushiki Kaisha Tokai Rika Denki Seisakusho LEE, WOO KYUNG 2815 §102§103 Non-Final OA — Pending Aug 12, 2024
18767917 POSITIVE POLE PIECE, ELECTROCHEMICAL DEVICE INCLUDING THE POSITIVE POLE PIECE, AND ELECTRONIC DEVICE Calb Group Co., Ltd. BROWN, MADISON ELIZABETH §103 Non-Final OA — Pending Jul 09, 2024
18650126 NEGATIVE ELECTRODE SHEET, SECONDARY BATTERY AND ELECTRICAL DEVICE Calb Group Co., Ltd. MATHEW, ISWARYA 1788 §103 Non-Final OA — Pending Apr 30, 2024
18703719 DRUG INFUSION DEVICE WITH INTEGRATED POWER SUPPLY AND ARTIFICIAL PANCREAS Medtrum Technologies Inc. PATEL, SHEFALI DILIP 3783 §102§103§112Other Non-Final OA — Pending Apr 23, 2024
18703366 CLOSED-LOOP ARTIFICIAL PANCREAS INSULIN INFUSION CONTROL SYSTEM Medtrum Technologies Inc. SKRZYCKI, JONATHAN MICHAEL 2116 §112 Final Rejection — Pending Apr 22, 2024
18703368 CLOSED-LOOP ARTIFICIAL PANCREAS INSULIN INFUSION CONTROL SYSTEM Medtrum Technologies Inc. VU, QUYNH-NHU HOANG 3783 §102§103§112 Non-Final OA — Pending Apr 22, 2024
18703363 CLOSED-LOOP ARTIFICIAL PANCREAS INSULIN INFUSION CONTROL SYSTEM Medtrum Technologies Inc. TURKOWSKI, KAYLA MARIE 3783 §103§112 Non-Final OA — Pending Apr 22, 2024
18695366 CALIBRATION FREE ANALYTE DETECTION DEVICE Medtrum Technologies Inc. DOUGHERTY, SEAN PATRICK 3791 §103 Final Rejection 40d Pending Mar 26, 2024
18694994 CALIBRATION FREE ANALYTE DETECTION DEVICE Medtrum Technologies Inc. DOUGHERTY, SEAN PATRICK 3791 §103§112 Final Rejection — Pending Mar 25, 2024
18694420 ANALYTE DETECTION DEVICE AND DETECTION METHOD Medtrum Technologies Inc. TOTH, KAREN E 3791 §102§112 Final Rejection 69d Pending Mar 22, 2024
18693954 SENSOR CALIBRATION METHOD AND ANALYTE DETECTION DEVICE Medtrum Technologies Inc. LAU, TUNG S 2857 §101 Final Rejection — Pending Mar 21, 2024
18692833 INSTALLATION UNIT OF ANALYTE DETECTION DEVICE Medtrum Technologies Inc. CHEN, TSE W 3791 §112 Non-Final OA 17d overdue Pending Mar 18, 2024
18592537 ANTI-FOGGING COMPOSITION AND ANTI-FOGGING PLASTICS PREPARED THEREFROM Nano And Advanced Materials Institute Limited LEONARD, MICHAEL L 1763 §103 Non-Final OA — Pending Mar 01, 2024
18578008 ANALYTE DETECTION DEVICE WITH MULTILAYER ADHESIVE TAPE Medtrum Technologies Inc. KERN, ASHLEIGH LAUREN 3794 §103 Non-Final OA — Pending Jan 10, 2024
18406179 WEAKLY-CENTRALIZED FREQUENCY REGULATION CONTROL METHOD OF CHARGE STATION CLUSTER BASED ON VIRTUAL LEADER AND MEDIUM Wuhan University ORTIZ, ELIM 2117 §102§112 Non-Final OA — Pending Jan 07, 2024
18576370 BODY FLUID ANALYTE DETECTION DEVICE Medtrum Technologies Inc. GLOVER, NELSON ALEXANDER 3791 §112 Non-Final OA 69d Pending Jan 04, 2024
18562840 ANALYTE DETECTION DEVICE WITH CIRCUIT BOARD AND SHELL INTEGRATION Medtrum Technologies Inc. DOUGHERTY, SEAN PATRICK 3791 §102§103 Final Rejection — Pending Nov 21, 2023
18562838 BATTERY SHELL INTEGRATED ANALYTE DETECTION DEVICE Medtrum Technologies Inc. DAULTON, CHRISTINA RENEE 1729 §103 Final Rejection — Pending Nov 21, 2023
18562836 BATTERY SHELL INTEGRATED ANALYTE DETECTION DEVICE Medtrum Technologies Inc. PATEL, OM 3791 §103 Non-Final OA 15d overdue Pending Nov 21, 2023
18508238 Substrate and semiconductor module Absolics Inc. SYLVIA, CHRISTINA A 2817 §103 Final Rejection — Pending Nov 14, 2023
18458159 METHOD OF MANUFACTURING PACKAGING SUBSTRATE AND PACKAGING SUBSTRATE MANUFACTURED THEREBY Absolics Inc. SABUR, ALIA 2812 §103 Non-Final OA — Pending Aug 30, 2023
18273268 REGENERATED POLYMER ALLOY MATERIAL AND METHOD FOR PREPARING SAME China National Electric Apparatus Research Institute Co., Ltd. DARLING, DEVIN MITCHELL 1764 §103 Final Rejection — Pending Jul 19, 2023
18269963 DRUG INFUSION DEVICE WITH EMBEDDED POWER SUPPLY Medtrum Technologies Inc. SMALE, AVERY E 3783 §102§103 Non-Final OA — Pending Jun 28, 2023
18269957 SKIN PATCH DRUG INFUSION DEVICE Medtrum Technologies Inc. WITTLIFF, KATERINA ANNA 3783 §103 Final Rejection 69d Pending Jun 28, 2023
18035939 SKIN PATCH DRUG INFUSION SYSTEM Medtrum Technologies Inc. DANIEL, ANTARIUS S 3783 §103 Final Rejection — Pending May 09, 2023
18034070 DRIVING STRUCTURE OF A DRUG INFUSION DEVICE Medtrum Technologies Inc. CARPENTER, WILLIAM R 3783 §103 Non-Final OA 7d Pending Apr 27, 2023
18034066 PATCH-TYPE DRUG INFUSION DEVICE Medtrum Technologies Inc. PRICE, NATHAN R 3783 §103§112 Final Rejection — Pending Apr 27, 2023
18301960 ENERGY STORAGE CONTAINER AND ASSEMBLY METHOD THEREOF Calb Group Co., Ltd. JONES, OLIVIA ANN 1789 §102§103 Non-Final OA 7d Pending Apr 17, 2023
18297627 CYLINDRICAL BATTERY Calb Group Co., Ltd. HEMINGWAY, TIMOTHY G 1754 §103 Non-Final OA — Pending Apr 09, 2023
18022755 NEEDLE MECHANISM MODULE FOR DRUG INFUSION DEVICE Medtrum Technologies Inc. SMALE, AVERY E 3783 §102§112 Non-Final OA 12d Pending Feb 23, 2023
18022524 CLOSED-LOOP ARTIFICIAL PANCREAS INSULIN INFUSION CONTROL SYSTEM Medtrum Technologies Inc. SMALE, AVERY E 3783 §103 Final Rejection 22d Pending Feb 22, 2023
18105233 MOLECULAR BEACON BASED NANOPROBES FOR DIRECTLY DETECTING ORGAN-SPECIFIC MATASTASIS RELATED BIOMARKERS OF TUMOR CELLS IN PERIPHERAL BLOOD, PREPARATION METHOD AND APPLICATION Wuhan University MUMMERT, STEPHANIE KANE 1681 §103 Final Rejection 83d Pending Feb 02, 2023
18015331 BODY FLUID ANALYTE DETECTION DEVICE AND CONTINUOUS GLUCOSE MONITORING DEVICE Medtrum Technologies Inc. GLOVER, NELSON ALEXANDER 3791 §103 Final Rejection — Pending Jan 10, 2023
18015079 BODY FLUID ANALYTE DETECTION DEVICE Medtrum Technologies Inc. CATINA, MICHAEL ANTHONY 3791 §102§103§112 Final Rejection 2d overdue Pending Jan 09, 2023
18150793 BATTERY Calb Co., Ltd. KENLAW, GRACE A 1723 §102 Non-Final OA 35d overdue Pending Jan 06, 2023
18085546 BATTERY AND MANUFACTURING METHOD FOR BATTERY Calb Co., Ltd. FRANCIS, ADAM JOSEPH 1728 §103 Non-Final OA 8d overdue Pending Dec 20, 2022
18079845 BATTERY MODULE AND BATTERY PACK Calb Co., Ltd. DIGNAN, MICHAEL L 1723 §103 Non-Final OA 9d overdue Pending Dec 12, 2022
17924120 BILATERALLY DRIVEN CLOSED-LOOP ARTIFICIAL PANCREAS Medtrum Technologies Inc. LANGE, ERIC A 3783 §112 Non-Final OA 71d Pending Nov 09, 2022
17984227 BATTERY PACK, ASSEMBLY METHOD FOR BATTERY PACK, AND DISASSEMBLY METHOD FOR BATTERY PACK Calb Co., Ltd. ESTES, JONATHAN WILLIAM 1725 §102§103§112 Non-Final OA — Pending Nov 09, 2022
17924119 UNIDIRECTIONAL-DRIVEN DRUG INFUSION DEVICE Medtrum Technologies Inc. WITTLIFF, KATERINA ANNA 3783 §103 Non-Final OA 30d Pending Nov 09, 2022
17978216 BATTERY CASE AND BATTERY DEVICE Calb Co., Ltd. NEWMAN, DREW C 1751 §103§112 Non-Final OA 34d Pending Nov 01, 2022
17974539 BATTERY AND MANUFACTURING METHOD FOR BATTERY Calb Co., Ltd. ESTES, JONATHAN WILLIAM 1725 §103§112 Non-Final OA — Pending Oct 27, 2022
17971646 BATTERY, BATTERY APPARATUS AND BATTERY MANUFACTURING METHOD Calb Co., Ltd. KERNS, KEVIN P 1735 §103 Final Rejection 62d Pending Oct 24, 2022
17955559 OPTICAL IMAGING SYSTEM FOR PRESENTING IMAGE OF PARTICLE Flowview Tek LAPAGE, MICHAEL P 2877 §103§112 Final Rejection 6d Pending Sep 29, 2022

View all 57 →

Managing Jcip Global Inc.'s Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

What is Jcip Global Inc.'s patent allowance rate?

87.2% of resolved applications prosecuted by Jcip Global Inc. were allowed, across 56,542 applications in USPTO records.

How many office actions does Jcip Global Inc. average before allowance?

2.60 office actions per allowed application on average.

How many pending office actions does Jcip Global Inc. have?

57 pending office actions as of October 2026, for 10 clients, before 49 examiners in 29 art units.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month